Development of Rous sarcoma Virus-like Particles Displaying hCC49 scFv for Specific Targeted Drug Delivery to Human Colon Carcinoma Cells
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Development of Rous sarcoma Virus-like Particles Displaying hCC49 scFv for Specific Targeted Drug Delivery to Human Colon Carcinoma Cells
Authors
Keywords
drug delivery, colon carcinoma, <em class=EmphasisTypeItalic >Rous sarcoma</em> virus-like particles, silkworm, doxorubicin
Journal
PHARMACEUTICAL RESEARCH
Volume 32, Issue 11, Pages 3699-3707
Publisher
Springer Nature
Online
2015-06-06
DOI
10.1007/s11095-015-1730-2
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Chimeric Virus-Like Particles Made Using GAG and M1 Capsid Proteins Providing Dual Drug Delivery and Vaccination Platform
- (2015) Vipin K. Deo et al. MOLECULAR PHARMACEUTICS
- A Model for Targeting Colon Carcinoma Cells Using Single-Chain Variable Fragments Anchored on Virus-Like Particles via Glycosyl Phosphatidylinositol Anchor
- (2014) Vipin Kumar Deo et al. PHARMACEUTICAL RESEARCH
- Bioengineering virus-like particles as vaccines
- (2013) Linda H.L. Lua et al. BIOTECHNOLOGY AND BIOENGINEERING
- Reengineering viruses and virus-like particles through chemical functionalization strategies
- (2013) Mark Thomas Smith et al. CURRENT OPINION IN BIOTECHNOLOGY
- Phototriggered cargo release from virus-like assemblies
- (2013) Melanie Brasch et al. FARADAY DISCUSSIONS
- A Cholesterol Recognition Amino Acid Consensus Domain in GP64 Fusion Protein Facilitates Anchoring of Baculovirus to Mammalian Cells
- (2013) A. Luz-Madrigal et al. JOURNAL OF VIROLOGY
- Virus-like particles with removable cyclodextrins enable glutathione-triggered drug release in cells
- (2013) Kenichi Niikura et al. Molecular BioSystems
- Construction and Characterization of Virus-Like Particles: A Review
- (2012) Andris Zeltins MOLECULAR BIOTECHNOLOGY
- Disassembly and reassembly improves morphology and thermal stability of human papillomavirus type 16 virus-like particles
- (2012) Qinjian Zhao et al. Nanomedicine-Nanotechnology Biology and Medicine
- Virosome: A novel vector to enable multi-modal strategies for cancer therapy
- (2011) Yasufumi Kaneda ADVANCED DRUG DELIVERY REVIEWS
- Antibody-targeted nanoparticles for cancer therapy
- (2011) Francois Fay et al. Immunotherapy
- Production of Rous sarcoma virus-like particles displaying human transmembrane protein in silkworm larvae and its application to ligand–receptor binding assay
- (2011) Yoshitaka Tsuji et al. JOURNAL OF BIOTECHNOLOGY
- Expression of an RSV-gag virus-like particle in insect cell lines and silkworm larvae
- (2011) Vipin Kumar Deo et al. JOURNAL OF VIROLOGICAL METHODS
- A pH-Sensitive Heparin-Binding Sequence from Baculovirus gp64 Protein Is Important for Binding to Mammalian Cells but Not to Sf9 Insect Cells
- (2011) C. Wu et al. JOURNAL OF VIROLOGY
- Fabrication of influenza virus-like particles using M2 fusion proteins for imaging single viruses and designing vaccines
- (2011) Hung-Ju Wei et al. VACCINE
- Autographa californica Multicapsid Nucleopolyhedrovirus Efficiently Infects Sf9 Cells and Transduces Mammalian Cells via Direct Fusion with the Plasma Membrane at Low pH
- (2010) S. Dong et al. JOURNAL OF VIROLOGY
- Transduction of Human Primitive Repopulating Hematopoietic Cells With Lentiviral Vectors Pseudotyped With Various Envelope Proteins
- (2010) Yoon-Sang Kim et al. MOLECULAR THERAPY
- Host proteins involved in HIV infection: New therapeutic targets
- (2009) Nathalie Arhel et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- HVJ envelope vector, a versatile delivery system: Its development, application, and perspectives
- (2008) Qingxian Zhang et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started